Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endocytosis | 10 | 2015 | 118 | 1.620 |
Why?
|
| Receptor, Cannabinoid, CB1 | 4 | 2018 | 41 | 1.520 |
Why?
|
| Neurons | 11 | 2025 | 1263 | 1.380 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2017 | 93 | 0.970 |
Why?
|
| Microscopy, Fluorescence | 4 | 2015 | 256 | 0.920 |
Why?
|
| Signal Transduction | 8 | 2018 | 2157 | 0.900 |
Why?
|
| Arrestins | 3 | 2017 | 28 | 0.900 |
Why?
|
| Receptors, Opioid, mu | 3 | 2015 | 52 | 0.870 |
Why?
|
| Cell Membrane | 7 | 2015 | 403 | 0.750 |
Why?
|
| Receptors, AMPA | 3 | 2013 | 58 | 0.710 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 5 | 2003 | 28 | 0.650 |
Why?
|
| Hippocampus | 6 | 2015 | 594 | 0.640 |
Why?
|
| Exocytosis | 2 | 2009 | 49 | 0.560 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2017 | 38 | 0.520 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2017 | 200 | 0.480 |
Why?
|
| Corpus Striatum | 2 | 2015 | 121 | 0.430 |
Why?
|
| Transport Vesicles | 1 | 2014 | 22 | 0.430 |
Why?
|
| Arachidonic Acids | 4 | 2020 | 25 | 0.430 |
Why?
|
| Synapses | 2 | 2013 | 185 | 0.410 |
Why?
|
| Rats | 12 | 2020 | 3735 | 0.400 |
Why?
|
| Receptors, Adrenergic, beta-2 | 3 | 2010 | 19 | 0.400 |
Why?
|
| rab4 GTP-Binding Proteins | 2 | 2012 | 2 | 0.400 |
Why?
|
| Protein Transport | 6 | 2015 | 296 | 0.390 |
Why?
|
| Tryptophan | 2 | 2003 | 66 | 0.390 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2012 | 13 | 0.370 |
Why?
|
| Animals | 19 | 2025 | 16992 | 0.330 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2010 | 54 | 0.330 |
Why?
|
| Membrane Proteins | 2 | 2013 | 561 | 0.330 |
Why?
|
| Calcium Signaling | 1 | 2010 | 107 | 0.310 |
Why?
|
| Analgesics, Opioid | 1 | 2012 | 252 | 0.300 |
Why?
|
| Endocannabinoids | 4 | 2020 | 41 | 0.300 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2007 | 80 | 0.280 |
Why?
|
| RNA, Small Interfering | 2 | 2025 | 436 | 0.280 |
Why?
|
| Cells, Cultured | 7 | 2025 | 1621 | 0.280 |
Why?
|
| Computer Systems | 1 | 2007 | 19 | 0.270 |
Why?
|
| Glycerides | 3 | 2018 | 12 | 0.270 |
Why?
|
| Enzyme Inhibitors | 3 | 2006 | 458 | 0.260 |
Why?
|
| Isothiuronium | 2 | 2003 | 2 | 0.250 |
Why?
|
| Protein Binding | 5 | 2018 | 1082 | 0.240 |
Why?
|
| Clathrin | 4 | 2014 | 21 | 0.230 |
Why?
|
| Naphthalenes | 2 | 2016 | 38 | 0.230 |
Why?
|
| Phosphorylation | 6 | 2018 | 986 | 0.230 |
Why?
|
| Benzoxazines | 2 | 2016 | 47 | 0.230 |
Why?
|
| Morpholines | 2 | 2016 | 72 | 0.220 |
Why?
|
| Time Factors | 6 | 2015 | 1857 | 0.220 |
Why?
|
| Potassium Channels | 1 | 2025 | 80 | 0.220 |
Why?
|
| Seizures | 1 | 2025 | 79 | 0.220 |
Why?
|
| Epilepsy | 1 | 2025 | 59 | 0.210 |
Why?
|
| Humans | 15 | 2025 | 43102 | 0.210 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2017 | 108 | 0.210 |
Why?
|
| GTP-Binding Proteins | 3 | 2018 | 59 | 0.210 |
Why?
|
| Ligands | 2 | 2015 | 388 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2020 | 1766 | 0.200 |
Why?
|
| Cell Line | 5 | 2018 | 1410 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 1 | 2025 | 386 | 0.190 |
Why?
|
| Green Fluorescent Proteins | 4 | 2013 | 209 | 0.160 |
Why?
|
| Amidohydrolases | 1 | 2020 | 12 | 0.160 |
Why?
|
| Clathrin-Coated Vesicles | 2 | 2012 | 2 | 0.160 |
Why?
|
| TRPV Cation Channels | 1 | 2020 | 24 | 0.160 |
Why?
|
| Anti-Anxiety Agents | 1 | 2020 | 19 | 0.160 |
Why?
|
| Embryo, Mammalian | 2 | 2014 | 157 | 0.160 |
Why?
|
| Serotonin | 1 | 2020 | 123 | 0.150 |
Why?
|
| Nucleus Accumbens | 1 | 2020 | 100 | 0.150 |
Why?
|
| Phenylurea Compounds | 1 | 2018 | 18 | 0.150 |
Why?
|
| Allosteric Regulation | 1 | 2018 | 27 | 0.150 |
Why?
|
| Carbazoles | 2 | 2010 | 49 | 0.140 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2009 | 27 | 0.140 |
Why?
|
| Isoproterenol | 2 | 2009 | 39 | 0.140 |
Why?
|
| Peptides | 1 | 2000 | 372 | 0.130 |
Why?
|
| Cannabinoids | 1 | 2017 | 73 | 0.120 |
Why?
|
| Mutation | 2 | 2013 | 1177 | 0.120 |
Why?
|
| Binding Sites | 3 | 2003 | 671 | 0.120 |
Why?
|
| G-Protein-Coupled Receptor Kinases | 1 | 2016 | 7 | 0.120 |
Why?
|
| Mutant Proteins | 1 | 2016 | 51 | 0.120 |
Why?
|
| Protein Kinases | 1 | 2016 | 100 | 0.120 |
Why?
|
| Protein Isoforms | 1 | 2016 | 139 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 196 | 0.120 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2015 | 19 | 0.120 |
Why?
|
| Molecular Biology | 1 | 2015 | 47 | 0.110 |
Why?
|
| Models, Biological | 2 | 2016 | 712 | 0.100 |
Why?
|
| Receptors, Cell Surface | 2 | 2007 | 146 | 0.100 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2013 | 21 | 0.100 |
Why?
|
| Genetic Engineering | 1 | 2013 | 37 | 0.100 |
Why?
|
| Ouabain | 2 | 2003 | 15 | 0.100 |
Why?
|
| Adenosine Deaminase | 1 | 2013 | 21 | 0.100 |
Why?
|
| Cations | 2 | 2003 | 50 | 0.100 |
Why?
|
| Dendrites | 2 | 2010 | 57 | 0.100 |
Why?
|
| RNA Editing | 1 | 2013 | 37 | 0.100 |
Why?
|
| Kv1.4 Potassium Channel | 1 | 2013 | 1 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2013 | 186 | 0.100 |
Why?
|
| Sodium | 2 | 2003 | 102 | 0.100 |
Why?
|
| COS Cells | 1 | 2013 | 68 | 0.100 |
Why?
|
| Ethanol | 1 | 2015 | 224 | 0.100 |
Why?
|
| Protein Stability | 1 | 2013 | 48 | 0.100 |
Why?
|
| Molecular Imaging | 1 | 2013 | 30 | 0.100 |
Why?
|
| Pyramidal Cells | 1 | 2013 | 65 | 0.100 |
Why?
|
| Erythrocytes | 2 | 2003 | 126 | 0.090 |
Why?
|
| Anxiety | 1 | 2020 | 874 | 0.090 |
Why?
|
| Myosin Type V | 1 | 2012 | 1 | 0.090 |
Why?
|
| Myosin Heavy Chains | 1 | 2012 | 18 | 0.090 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2012 | 13 | 0.090 |
Why?
|
| Myosins | 1 | 2012 | 35 | 0.090 |
Why?
|
| Light | 1 | 2013 | 185 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2016 | 1271 | 0.090 |
Why?
|
| Propanolamines | 1 | 2010 | 13 | 0.080 |
Why?
|
| Dopamine | 3 | 2002 | 275 | 0.080 |
Why?
|
| Propranolol | 1 | 2010 | 18 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2010 | 154 | 0.080 |
Why?
|
| Central Nervous System | 1 | 2010 | 152 | 0.080 |
Why?
|
| Receptors, Transferrin | 1 | 2009 | 15 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 1070 | 0.070 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2009 | 74 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 388 | 0.070 |
Why?
|
| Coated Pits, Cell-Membrane | 1 | 2007 | 2 | 0.070 |
Why?
|
| Organ Culture Techniques | 1 | 2007 | 101 | 0.070 |
Why?
|
| Transfection | 2 | 2006 | 532 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2007 | 352 | 0.060 |
Why?
|
| Microscopy, Video | 1 | 2006 | 15 | 0.060 |
Why?
|
| Neuronal Plasticity | 1 | 2007 | 126 | 0.060 |
Why?
|
| Diagnostic Imaging | 1 | 2006 | 53 | 0.060 |
Why?
|
| Pyrroles | 1 | 2006 | 72 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2006 | 150 | 0.060 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2006 | 95 | 0.060 |
Why?
|
| Kinetics | 2 | 2003 | 695 | 0.050 |
Why?
|
| Indoles | 1 | 2006 | 187 | 0.050 |
Why?
|
| Sodium Radioisotopes | 1 | 2003 | 1 | 0.050 |
Why?
|
| Rubidium | 1 | 2003 | 6 | 0.050 |
Why?
|
| Biological Transport, Active | 1 | 2003 | 27 | 0.050 |
Why?
|
| Swine | 1 | 2003 | 212 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 184 | 0.050 |
Why?
|
| Dynamin II | 1 | 2002 | 11 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 665 | 0.050 |
Why?
|
| Proline-Rich Protein Domains | 1 | 2000 | 7 | 0.040 |
Why?
|
| src Homology Domains | 1 | 2000 | 14 | 0.040 |
Why?
|
| Opossums | 1 | 2000 | 11 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2000 | 97 | 0.040 |
Why?
|
| Serine | 1 | 2000 | 79 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2020 | 78 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2003 | 876 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2025 | 1869 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 1596 | 0.040 |
Why?
|
| Cyclohexanols | 1 | 2018 | 11 | 0.040 |
Why?
|
| Allosteric Site | 1 | 2018 | 12 | 0.040 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2018 | 15 | 0.040 |
Why?
|
| Mice | 2 | 2025 | 6644 | 0.030 |
Why?
|
| Pyridines | 1 | 2018 | 139 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2013 | 883 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2013 | 23 | 0.030 |
Why?
|
| Xenopus | 1 | 2013 | 48 | 0.030 |
Why?
|
| Oligonucleotides | 1 | 2013 | 49 | 0.030 |
Why?
|
| Fluorescence | 1 | 2013 | 118 | 0.020 |
Why?
|
| Male | 2 | 2025 | 23409 | 0.020 |
Why?
|
| Base Sequence | 1 | 2013 | 983 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 1542 | 0.020 |
Why?
|
| Sequence Analysis, Protein | 1 | 2010 | 52 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2010 | 138 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 1772 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 423 | 0.020 |
Why?
|
| Dynamin III | 1 | 2007 | 4 | 0.020 |
Why?
|
| Synaptic Vesicles | 1 | 2007 | 31 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2007 | 56 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2007 | 321 | 0.010 |
Why?
|
| Dynamins | 1 | 2002 | 16 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 52 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 68 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 197 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2002 | 224 | 0.010 |
Why?
|
| Plasmids | 1 | 2002 | 244 | 0.010 |
Why?
|
| Adaptor Protein Complex alpha Subunits | 1 | 2000 | 1 | 0.010 |
Why?
|
| Oxymetazoline | 1 | 2000 | 2 | 0.010 |
Why?
|
| Inositol Phosphates | 1 | 2000 | 8 | 0.010 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2000 | 14 | 0.010 |
Why?
|
| Female | 1 | 2015 | 24698 | 0.010 |
Why?
|